Remove 2016 Remove BioTech Remove Health Policy
article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

When this occurred, it didn’t cause more than a ripple of interest outside biotech. Yet the trust relationship with technology companies, even after the 2016 Cambridge Analytica event, is different and it’s clearly stronger than it is with health insurers. But the U.S. citizens’ personal data. Should it be?

article thumbnail

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

consumers trusted the biotech health industry segment compared with the pharmaceutical segment. President Trump’s platform when running for office in 2016 was to deal with the cost of prescription drugs, discussed in his conversation with TIME magazine when he put the drug industry “on notice,” in the words of CNN.

article thumbnail

Two-Thirds of Americans Say Healthcare Doesn’t Work Well, in RealClear Politics Poll

Health Populi

This group is less likely to support universal health care or the guarantee of pre-existing condition coverage, yet are more keen on access to treatment for drug and alcohol service. Technology, biotech, hospitals, and life science companies would be the health care improvers, most Americans told RealClear pollsters.